1 |
Griffith, T.S. and D.H. Lynch, "TRAIL: a molecule with multiple receptors and control mechanisms" Curr. Opin. Immunol, Vol. 10, pp. 559-563, 1998.
DOI
|
2 |
Zhang, X.D., A. Franco, K. Myers, C.Gray, T.Nguyen and P.Hersey, "Relation of TNF-related apoptosis in ducing ligand (TRAIL) receptor and FLICE inhibitory protein expression to TRAIL induced apoptosis of melanoma," Cancer Res, Vol. 59, pp. 264-295, 1999.
|
3 |
Dongyeon Lee, Seongjin Ko, Sesik Kang, Changsoo Kim, Donghyun Kim, Junghoon Kim, “Dose Evaluation of Childhood Leukemia in Total Body Irradiation,” Journal of Korean Society of Radiology, Vol. 7, No. 4, pp. 259-264, 2013.
DOI
|
4 |
Karson S Putt, Grace W Chen, Jennifer M Pearson, Joseph S Sandhorst, Martin S Hoagland, Jung-Taek Kwon, Soon-Kyung Hwang, Hua Jin, Mona I Church well, Myung-Haing Cho, Daniel R Doerge, William G Helferich & Paul J Hergenrother, "Small-molecule activation of procaspase-3 to caspase-3 as a personalized anticancer strategy," Journal of Nature Chemical Biology, Vol. 2, pp. 543-550, 2006.
DOI
|
5 |
David Wallach, Mark Boldin, Eugene Varfolomeev, Rudi Beyaert, Peter Vandenabeele, Walter Fiers, “Cell death induction by receptors of the TNF family: towards a molecular understanding,” Journal of FEBS letters, Vol. 410, No. 1, pp. 96-106, 1997.
DOI
|
6 |
Byung Geol Jeong, Soon Young Kim, Kon Joo Lee and Jong Sik Kim, "Up-Regulation of NAG-1 and p21 Genes by Sulforaphane," Journal of Life Science,Vol. 22, No. 3, pp. 360-365, 2012.
DOI
|
7 |
Jihae Lee, Kyung-Ja Leeongyeon Lee, "Clinical Factors Predicting the Pathologic Tumor Response after Preoperative Concurrent Chemoradiotherapy for Rectal Cancer," Journal of radiation oncology, Vol. 26, No.4, pp. 213-221, 2008.
|
8 |
O'Connell MJ, Martenson JA, Wieand HS, et al. "Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery" N Engl J Med, Vol. 331, pp. 502-507, 1994.
DOI
|
9 |
Gastrointestinal Tumor Study Group. "Prolongation of the disease-free interval in surgically treated rectal carcinoma," N Engl J Med, Vol. 312, pp.165-192, 1985.
DOI
|
10 |
Krook JE, Moertel CG, Gunderson LL, et al. "Effective surgical adjuvant therapy for high-risk rectal carcinoma," N Engl J Med, Vol. 324, pp. 709-715, 1991.
DOI
|
11 |
Gastrointestinal Tumor Study Group. "Radiation therapy and fluoro uracial with or without semustine for the treatment of patients with surgical adjuvant aden ocarcinoma of the rectum," J Clin Oncol, Vol. 10, pp.549-557, 1992.
DOI
|
12 |
Wang, S and S. W. El-Deiry "TRAIL and apoptosis induction by TNF-family death receptors" oncogene Vol. 22, pp. 862-863, 2001.
|
13 |
French, L.E and J.Tschopp, "The TRAIL to selective tumor death," Nat. Med, Vol. 5, pp. 146-147, 1999.
DOI
|
14 |
Srivastava, R.K. "TRAIL/Apo-2L: mechanisms and clinical applications in cancer," Neoplasia Vol. 3, pp. 535-546, 2001.
DOI
|
15 |
Anderson, D.M, E.Maraskovsky, W.L.Billingsley, W. C. Dougall, M.E. Tometsko, E.R.Roux, M.C. Teepe, R.F. DuBose, D.Cosman, L.Galibert, "A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function," Nature, Vol. 390, 175-179, 1997.
DOI
|